Clinical pharmacology and pharmacogenetics in a genomics era: the DMET platform

In vitroevidence for the role of OATP and OCT uptake transporters in drug–drug interactions

(2009) Jürgen Kindla et al.   Expert Opinion on Drug Metabolism & Toxicology

Gene-environment interactions in asthma

(2009) Erika von Mutius   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin

(2009) Ann K Daly et al.   NATURE GENETICS

Sequence variants at the TERT-CLPTM1L locus associate with many cancer types

(2009) Thorunn Rafnar et al.   NATURE GENETICS

Genetic ancestry modifies pharmacogenetic gene–gene interaction for asthma

(2009) Harriet Corvol et al.   Pharmacogenetics and Genomics

CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population

(2009) Paola Borgiani et al.   PHARMACOGENOMICS

Pharmacogenomic progress in individualized dosing of key drugs for cancer patients

(2009) Christine M Walko et al.   Nature clinical practice. Oncology

Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation

(2008) Ulrich M. Zanger et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

CYP4F2 genetic variant alters required warfarin dose

(2008) M. D. Caldwell et al.   BLOOD

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

(2008) G. M. Cooper et al.   BLOOD

Pharmacogenetic Pathway Analysis of Docetaxel Elimination

(2008) SD Baker et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Effect of Environmental Substances on the Activity of Arylamine N-Acetyltransferases

(2008) Fernando Rodrigues-Lima et al.   CURRENT DRUG METABOLISM

Clinical Pharmacogenetics and Potential Application in Personalized Medicine

(2008) Shu-Feng Zhou et al.   CURRENT DRUG METABOLISM

CYP450 pharmacogenetics for personalizing cancer therapy

(2008) Ron H.N. van Schaik   DRUG RESISTANCE UPDATES

Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100

(2008) Bryan P. Schneider et al.   JOURNAL OF CLINICAL ONCOLOGY

Multiple loci identified in a genome-wide association study of prostate cancer

(2008) Gilles Thomas et al.   NATURE GENETICS

Multiple newly identified loci associated with prostate cancer susceptibility

(2008) Rosalind A Eeles et al.   NATURE GENETICS

SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Cytochrome P-450 Polymorphisms and Response to Clopidogrel

(2008) Jessica L. Mega et al.   NEW ENGLAND JOURNAL OF MEDICINE

PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics

(2008) Bin Zhang et al.   PHARMACOGENOMICS

EGFR-targeted therapies in lung cancer: predictors of response and toxicity

(2008) Rebecca Suk Heist et al.   PHARMACOGENOMICS

Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions

(2008) M R Nelson et al.   PHARMACOGENOMICS JOURNAL